Revenue
2020
2021
2022
2023
2024
2025
Virbac (VIRP)
Price€319.00Cached quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €1.46B | €1.40B | €1.25B | €1.22B | €1.06B | €934.2M |
| Operating expenses | €745.0M | €709.3M | €623.9M | €606.5M | — | — |
| Operating income | €226.1M | €217.1M | €184.0M | €179.5M | €167.6M | €183.7M |
| Operating margin | 15.44% | 15.53% | 14.76% | 14.76% | 15.75% | 19.67% |
| EBITDA | €286.9M | €276.3M | €230.7M | €229.2M | — | — |
| EBITDA margin | 19.59% | 19.77% | 18.50% | 18.85% | — | — |
| Net income | €150.5M | €145.8M | €121.1M | €121.3M | €115.7M | €140.3M |
| Net profit margin | 10.27% | 10.43% | 9.71% | 9.97% | 10.87% | 15.02% |
| Basic EPSper basic share | €18.01 | €17.35 | €14.40 | €14.43 | €13.40 | €16.12 |
| Diluted EPSper diluted share | €18.00 | €17.34 | €14.38 | €14.42 | €13.38 | €16.12 |